![130274-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130274-Thumbnail%20Image.png?versionId=y2otTFmNxVfGdNlboOFY5tZyqTmTOPne&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240605/us-west-2/s3/aws4_request&X-Amz-Date=20240605T154426Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=3a8830c70f28afb2b8ae5b8804cf05fb2eb9ae8030624b569a5ff1321faffbf4&itok=3GiCMrZE)
![130284-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130284-Thumbnail%20Image.png?versionId=RL18_PeDsi0QZ7ifKxgMiJEVL3i4mc.x&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240606/us-west-2/s3/aws4_request&X-Amz-Date=20240606T054759Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f3d6b15d8c73c0cf7d6967a573a9bcefad0d52398c294984b06db431689cb0d5&itok=MkSjOHVT)
![130301-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130301-Thumbnail%20Image.png?versionId=xqj1fyeOr9I9fWJmok_xApUZSi.vLJWr&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240612/us-west-2/s3/aws4_request&X-Amz-Date=20240612T055045Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=3af1580345077680de92545cffca2847e8ddb7c9e7a997cee287918d1b3ade0f&itok=_EM0ee44)
![130302-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130302-Thumbnail%20Image.png?versionId=bRVeSoMNtjtOc8xFDxSUq67rlfgCYFH1&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240605/us-west-2/s3/aws4_request&X-Amz-Date=20240605T205427Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=5397aef26823e23c5d1b8a9b8546cb83c5d889ac489d568fdbe3d29d6b0d301f&itok=yeSP2o7w)
![130306-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130306-Thumbnail%20Image.png?versionId=v631S8PiiTl8DPeW3_O4fQhoei2bVdDu&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T235825Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=6c1cd2478f159cb077be2fd76969a673855b748a6716f3e7324dbf0bd8540a5a&itok=oFxZCiJK)
![130270-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/130270-Thumbnail%20Image.png?versionId=YWNgEwZ2.97XEslTr4xNKmSmiQp_YE6y&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T214513Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f177fdb12d2aefdc293276d319ccf8430f6dbe7f536e7d41f51107c5d2f5f759&itok=YfTLZqld)
![127836-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/127836-Thumbnail%20Image.png?versionId=Hk_Zg9FBwyn2Y5ifwyriHxPDtb9StJx3&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T125632Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e3f75447f852f1772e6c311eb4dd7180b3a3da8a7b8648cdc926920651f2d986&itok=vWgaj42V)
Previous proof-of-concept measurements on single-layer two-dimensional membrane-protein crystals performed at X-ray free-electron lasers (FELs) have demonstrated that the collection of meaningful diffraction patterns, which is not possible at synchrotrons because of radiation-damage issues, is feasible. Here, the results obtained from the analysis of a thousand single-shot, room-temperature X-ray FEL diffraction images from two-dimensional crystals of a bacteriorhodopsin mutant are reported in detail. The high redundancy in the measurements boosts the intensity signal-to-noise ratio, so that the values of the diffracted intensities can be reliably determined down to the detector-edge resolution of 4 Å. The results show that two-dimensional serial crystallography at X-ray FELs is a suitable method to study membrane proteins to near-atomic length scales at ambient temperature. The method presented here can be extended to pump–probe studies of optically triggered structural changes on submillisecond timescales in two-dimensional crystals, which allow functionally relevant large-scale motions that may be quenched in three-dimensional crystals.
![128522-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/128522-Thumbnail%20Image.png?versionId=ioDJu13rK54UH1QSTNB4B7esZCqXqDM3&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T051811Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=f1968fd6215d2d67831c04dd3b40edbe4efff54d79b7e307419e507e708abe87&itok=aNf-oH9o)
Structural studies on living cells by conventional methods are limited to low resolution because radiation damage kills cells long before the necessary dose for high resolution can be delivered. X-ray free-electron lasers circumvent this problem by outrunning key damage processes with an ultra-short and extremely bright coherent X-ray pulse. Diffraction-before-destruction experiments provide high-resolution data from cells that are alive when the femtosecond X-ray pulse traverses the sample. This paper presents two data sets from micron-sized cyanobacteria obtained at the Linac Coherent Light Source, containing a total of 199,000 diffraction patterns. Utilizing this type of diffraction data will require the development of new analysis methods and algorithms for studying structure and structural variability in large populations of cells and to create abstract models. Such studies will allow us to understand living cells and populations of cells in new ways. New X-ray lasers, like the European XFEL, will produce billions of pulses per day, and could open new areas in structural sciences.
![128510-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/128510-Thumbnail%20Image.png?versionId=TbkjmjfwnYNZLCEvSETH6Hvo1yHT5oQx&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T225211Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=36cdb51f3ec21d76babc8353bd2c77031c4e5ce9dc882735ef68449fa04d55f6&itok=TZSqn_eM)
We describe the deposition of four datasets consisting of X-ray diffraction images acquired using serial femtosecond crystallography experiments on microcrystals of human G protein-coupled receptors, grown and delivered in lipidic cubic phase, at the Linac Coherent Light Source. The receptors are: the human serotonin receptor 2B in complex with an agonist ergotamine, the human δ-opioid receptor in complex with a bi-functional peptide ligand DIPP-NH2, the human smoothened receptor in complex with an antagonist cyclopamine, and finally the human angiotensin II type 1 receptor in complex with the selective antagonist ZD7155. All four datasets have been deposited, with minimal processing, in an HDF5-based file format, which can be used directly for crystallographic processing with CrystFEL or other software. We have provided processing scripts and supporting files for recent versions of CrystFEL, which can be used to validate the data.
![129039-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/129039-Thumbnail%20Image.png?versionId=dj49DU2V7eKjuvZYfnjB9RcdmjEc8FzG&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T053426Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=048a69ec77ab157eaaabd65331b4c75068baab0ce1b822d475a77b9fb0c77924&itok=OHlUHgVY)
Background: Immunomodulatory drugs (IMiDs), such as lenalidomide, are therapeutically active compounds that bind and modulate the E3 ubiquitin ligase substrate recruiter cereblon, thereby affect steady-state levels of cereblon and cereblon binding partners, such as ikaros and aiolos, and induce many cellular responses, including cytotoxicity to multiple myeloma (MM) cells. Nevertheless, it takes many days for MM cells to die after IMiD induced depletion of ikaros and aiolos and thus we searched for other cereblon binding partners that participate in IMiD cytotoxicity.
Methods: Cereblon binding partners were identified from a MM cell line expressing histidine-tagged cereblon by pulling down cereblon and its binding partners and verified by co-immunoprecipitation. IMiD effects were determined by western blot analysis, cell viability assay, microRNA array and apoptosis analysis.
Results: We identified argonaute 2 (AGO2) as a cereblon binding partner and found that the steady-state levels of AGO2 were regulated by cereblon. Upon treatment of IMiD-sensitive MM cells with lenalidomide, the steady-state levels of cereblon were significantly increased, whereas levels of AGO2 were significantly decreased. It has been reported that AGO2 plays a pivotal role in microRNA maturation and function. Interestingly, upon treatment of MM cells with lenalidomide, the steady-state levels of microRNAs were significantly altered. In addition, silencing of AGO2 in MM cells, regardless of sensitivity to IMiDs, significantly decreased the levels of AGO2 and microRNAs and massively induced cell death.
Conclusion: These results support the notion that the cereblon binding partner AGO2 plays an important role in regulating MM cell growth and survival and AGO2 could be considered as a novel drug target for overcoming IMiD resistance in MM cells.